Tretinoin and Waldenstrom's macroglobulinaemia recurrent - from FDA reports
There is no Waldenstrom's macroglobulinaemia recurrent reported by people who take Tretinoin yet. This review analyzes which people have Waldenstrom's macroglobulinaemia recurrent with Tretinoin. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jan, 20, 2018
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Waldenstrom's macroglobulinaemia recurrent when taking Tretinoin?
- Check symptoms - is waldenstrom's macroglobulinaemia recurrent caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- write a post - share your experience related to the study
- More tools...
Expand the study to include all drugs with the same ingredientsWaldenstrom's macroglobulinaemia recurrent and drugs with ingredients of tretinoin.
Expand the study to include reports from both FDA and eHealthMeWaldenstrom's macroglobulinaemia recurrent and Tretinoin from FDA and eHealthMe reports
Tretinoin has active ingredients of tretinoin. It is often used in acne. (latest outcomes from Tretinoin 2,362 users)
Waldenstrom's Macroglobulinaemia Recurrent
Waldenstrom's macroglobulinaemia recurrent (repeatedly cancer affects small lymphocytes (white blood cells)) has been reported by people with waldenstrom's macroglobulinaemia, chronic obstructive pulmonary disease, stress and anxiety, pain (latest reports from 12 Waldenstrom's macroglobulinaemia recurrent patients).